Cardinal Health Reports Strong Q2 Results, Raises FY26 EPS Guidance Amidst Broad Segment Growth
CAH sits 77% above its 52-week low of $120.72.
Summary
Cardinal Health reported strong second-quarter fiscal year 2026 results, with significant revenue and earnings growth, and raised its full-year non-GAAP EPS guidance.
Key Events · Earnings and Guidance · CAH
-
Strong Q2 FY26 Financial Performance
Revenue increased 19% to $65.6 billion, non-GAAP operating earnings rose 38% to $877 million, and non-GAAP diluted EPS grew 36% to $2.63.
-
Raised Fiscal Year 2026 Outlook
The company increased its non-GAAP diluted EPS guidance for fiscal year 2026 to a range of $10.15 to $10.35, representing 23% to 26% growth.
-
Broad Segment Profit Growth
All operating segments achieved double-digit profit growth, including Pharmaceutical and Specialty Solutions (+29%), Global Medical Products and Distribution (+106%), and Other (+52%).
-
Capital Allocation and Financial Health
Cardinal Health completed an additional $375 million accelerated share repurchase program, bringing year-to-date repurchases to $750 million, and reached its targeted leverage range.
Analysis · CAH · Trade & Services
Cardinal Health delivered a robust second quarter, significantly exceeding prior-year performance across key financial metrics and raising its full-year guidance. The substantial growth in revenue, operating earnings, and diluted EPS, coupled with double-digit profit increases across all operating segments, indicates strong operational execution and market demand. The raised fiscal year 2026 non-GAAP EPS guidance provides a positive outlook, reinforcing investor confidence, especially as the company is trading near its 52-week high. Furthermore, the completion of $750 million in share repurchases and achieving its targeted leverage range demonstrate sound capital management and financial stability.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.4% of the 1304 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CAH was trading at $214.12 on NYSE in the Trade & Services sector, with a market capitalization of approximately $49.1B. The 52-week trading range was $120.72 to $220.27. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.